[HTML][HTML] Sex differences in Parkinson's disease

GE Gillies, IS Pienaar, S Vohra, Z Qamhawi - Frontiers in …, 2014 - Elsevier
Parkinson's disease (PD) displays a greater prevalence and earlier age at onset in men.
This review addresses the concept that sex differences in PD are determined, largely, by …

Molecular genetics of attention-deficit/hyperactivity disorder

SV Faraone, RH Perlis, AE Doyle, JW Smoller… - Biological …, 2005 - Elsevier
Results of behavioral genetic and molecular genetic studies have converged to suggest that
both genetic and nongenetic factors contribute to the development of attention …

SH-SY5Y human neuroblastoma cell line: in vitrocell model of dopaminergic neurons in Parkinson's disease

H **e, L Hu, G Li - Chinese medical journal, 2010 - journals.lww.com
Chinese Medical Journal Log in or Register Get new issue alertsGet alerts Secondary Logo
Journal Logo Advanced Search Toggle navigation Register Login HomeCurrently selected …

Environmental exposures and Parkinson's disease

S Nandipati, I Litvan - International journal of environmental research and …, 2016 - mdpi.com
Parkinson's disease (PD) affects millions around the world. The Braak hypothesis proposes
that in PD a pathologic agent may penetrate the nervous system via the olfactory bulb, gut …

MPTP mouse models of Parkinson's disease: an update

GE Meredith, DJ Rademacher - Journal of Parkinson's …, 2011 - content.iospress.com
Among the most widely used models of Parkinson's disease (PD) are those that employ
toxins, especially 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP). Depending on the …

Plasma membrane monoamine transporters: structure, regulation and function

GE Torres, RR Gainetdinov, MG Caron - Nature Reviews Neuroscience, 2003 - nature.com
The classical biogenic amine neurotransmitters—dopamine, noradrenaline, and 5-
hydroxytryptamine—control a variety of functions including locomotion, autonomic function …

Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder

GE Alexander - Dialogues in clinical neuroscience, 2004 - Taylor & Francis
Parkinson's disease (PD) is the second most common movement disorder. The
characteristic motor impairments-bradykinesia, rigidity, and resting tremor-result from …

Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity

RR Gainetdinov, WC Wetsel, SR Jones, ED Levin… - science, 1999 - science.org
The mechanism by which psychostimulants act as calming agents in humans with attention-
deficit hyperactivity disorder (ADHD) or hyperkinetic disorder is currently unknown. Mice …

Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter

SR Jones, RR Gainetdinov, RM Wightman… - Journal of …, 1998 - jneurosci.org
Amphetamine (AMPH) inhibits uptake and causes release of dopamine (DA) from
presynaptic terminals. AMPH can act on both vesicular storage of DA and directly on the …

Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders

VK Ramanan, AJ Saykin - American journal of …, 2013 - pmc.ncbi.nlm.nih.gov
The discovery of causative genetic mutations in affected family members has historically
dominated our understanding of neurodegenerative diseases such as Alzheimer's disease …